ACE2 and COVID-19: The authors concluded that individuals with AA have a slightly decreased risk of contracting COVID-19 [19], potentially due to the protective effect of increased levels of interferon-gamma among the AA patients, which downregulates angiotensin-converting enzyme 2 in the body, the SARS-CoV receptor [20].